Farnesoid X receptor-Acting through bile acids to treat metabolic disorders

Yanqiao Zhang1

  • 1Department of Integrative Medical Sciences Northeastern Ohio Universities College of Medicine 4209 State Route 44 Rootstown, OH 44272 yzhang@neoucom.edu.

Drugs of the Future
|January 28, 2014
PubMed

Insights

Farnesoid X receptor (FXR) regulates bile acid, lipid, and glucose balance. Targeting FXR offers a promising therapeutic strategy for metabolic disorders, with recent research highlighting its crucial role.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • The Farnesoid X receptor (FXR) is a nuclear receptor vital for metabolic homeostasis.
  • FXR regulates bile acid, lipid, and glucose metabolism.
  • Bile acids, FXR's natural ligands, can also trigger FXR-independent pathways.

Purpose of the Study:

  • To review recent advancements in understanding FXR's role in metabolic diseases.
  • To highlight FXR as a potential therapeutic target for metabolic disorders.

Main Methods:

  • Literature review of recent studies on FXR and metabolic disease.
  • Analysis of data from FXR agonist development and their metabolic effects.

Main Results:

  • FXR agonists have provided significant insights into FXR's metabolic functions.
  • FXR plays a critical role in maintaining metabolic homeostasis.
  • Emerging data support FXR as a viable therapeutic target.

Conclusions:

  • FXR is a key regulator of bile acid, lipid, and glucose metabolism.
  • Targeting FXR presents a promising avenue for treating metabolic disorders.
  • Continued research into FXR mechanisms is essential for therapeutic development.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.6K
Hepatic Drug Excretion: Enterohepatic Cycling01:17

Hepatic Drug Excretion: Enterohepatic Cycling

Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
3.6K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
818
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
9.0K